Esophagus hub from function to lesion
Masterclass RES multidisciplinare sull'esofago per gastroenterologi e chirurghi: dalla motilità alle lesioni neoplastiche, con casi clinici live e workshop pratici. Forlì, novembre 2026.
Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Smart ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.
Razionale scientifico
The esophagus represents one of the most stimulating challenges in modern medicine. The complexity of its diseases — from motility disorders to neoplasms, from inflammatory conditions to functional disorders — can no longer be addressed through a fragmented, single-speciality approach. Today, therapeutic success lies in the integration of expertise. Esophagus Hub has been created as a center of educational excellence, specifically designed for clinicians with early to intermediate experience who wish to elevate their professional practice through a comprehensive 360-degree perspective. The Big Picture: beyond the boundaries of a single specialty The distinctive value of this masterclass will be its multidisciplinary focus. You will not only learn what to do, but also understand why each clinical decision is made, by observing it from different perspectives: • Clinical Synergy: learn how gastroenterology, minimally invasive surgery, and advanced diagnostics come together for superior results. • Interaction with Experts: direct discussion with leading specialists in the field, facilitated by a strictly limited number of participants to ensure a highly personalized learning experience. • From Theory to "Live" practice: sessions featuring complex clinical cases and live cases (or high-resolution procedural videos) demonstrate how multidisciplinary decision-making is translated into practical, technical, and surgical action. Why participate? The goal of Esophagus Hub is not only to impart knowledge, but to provide an understanding of methods. You will learn to see patients with esophageal disease not as a collection of symptoms, but as part of a pathway shared among specialists. Through the analysis of real-world scenarios and interactive discussion, you will transform your technical expertise into comprehensive clinical mastery, enabling you to confidently address every diagnostic and therapeutic challenge in the field of esophageal diseases.
Luogo
Ospedale Morgagni Pierantoni
Via Forlanini, 34, Forlì (FC)
Programma
November 19, 2026· Forlì, Morgagni Pierantoni Hospital
- 10:00–12:00FUNCTIONAL DISEASE AND MOTILITY DISORDERS - part 1
- 10:00–10:20Imaging approach to motility disordersMarco Pantani (Cesena)
- 10:20–10:40Manometry and ph testingAurelio Mauro (Pavia)
- 10:40–11:00PPI and new drugs for GERDPierfrancesco Visaggi (Pisa)
- 11:00–12:00Clinical cases and live casesGaia Pellegatta (Rozzano), Daniele Mandolesi (Bologna)
- 12:00–13:00WORKSHOP 1: PPIs AND BARRIER DEVICESGiulia Gibiino (Forlì-Cesena), Monica Sbrancia (Forlì-Cesena), Edoardo Savarino (Padova), Rocco Maurizio Zagari (Bologna)
- 13:00–14:00Lunch
- 14:00–15:00FOCUS on EOSINOPHILIC ESOPHAGITIS
- 14:00–14:20Clinical suspicion and diagnostic workupEdoardo Savarino (Padova)
- 14:20–14:40Diagnostic mainstay: the pathologist's perspectiveGraziana Gallo (Cesena)
- 14:40–15:00Therapeutic managementGiovanni Marasco (Bologna)
- 15:00–15:30Discussion
- 15:30–17:30FUNCTIONAL DISEASE AND MOTILITY DISORDERS – part 2
- 15:30–15:50Endoscopic treatment of GERDAntonio Capogreco (Rozzano)
- 15:50–16:10Achalasia: the role of surgical treatmentRenato Salvador (Padova)
- 16:10–16:30Achalasia: endoscopic approach 2.0Paolo Cecinato (Bologna)
- 16:30–17:30Clinical cases and Live Cases
- 17:30–18:30WORKSHOP 2: IMAGING OF ESOPHAGUS AND MEDIASTINUMMarco Pantani (Cesena), Sara Piciucchi (Forlì)
- 17:30–18:30WORKSHOP 3: TBD
November 20, 2026· Forlì, Morgagni Pierantoni Hospital
- 8:30–10:30PRE-NEOPLASTIC LESIONS
- 8:30–8:50Diagnosis and characterization of preneoplastic lesionsSandro Sferrazza (Palermo)
- 8:50–9:10Endoscopic approach to dysplasiaRoberta Maselli (Rozzano)
- 9:10–9:30AI and esophageal diseaseCesare Hassan (Rozzano)
- 9:30–10:30Clinical cases and Live Cases
- 10:30–11:00Coffee Break
- 11:00–13:00ESOPHAGEAL ADENOCARCINOMA
- 11:00–11:20New options for chemotherapyAlessandro Bittoni (Meldola)
- 11:20–11:40The role of surgical treatmentUgo Elmore (Milano)
- 11:40–12:00Endoscopic stenting: when and how to perform itFrancesco Vito Mandarino (Milano)
- 12:00–13:00Clinical cases and Live Cases
- 13:00–14:00Lunch
- 14:00–15:30FOCUS-ON SUBEPITHELIAL LESIONS
- 14:00–14:20Diagnostic work-upPietro Fusaroli (Imola)
- 14:20–14:50Tandem Talk: endoscopic versus surgical treatmentMauro Manno (Carpi), Ugo Elmore (Milano)
- 14:50–15:30Clinical cases and discussion
- 15:30–17:30STENOSIS AND COMPLICATION MANAGEMENT
- 15:30–15:50Let's learn how to diagnose themSara Piciucchi (Forlì)
- 15:50–16:10Benign stenosis: which treatment?Marco Spadaccini (Rozzano)
- 16:10–16:30Endoscopic approach to leaksFrancesco Vito Mandarino (Milano)
- 16:30–16:50The role of the surgeonRenato Salvador (Padova)
- 16:50–17:30WORKSHOP 4: TBD
- 17:30End of the Masterclass
Responsabili del corso
MOMEDA EVENTI SRL
Provider
ID Provider: N° 684
Città: Bologna (BO)
Tipologia: Società, Agenzie Ed Enti Privati
Stato accreditamento: Standard - 1° Rinnovo
Carlo Fabbri
Responsabile scientifico
Specializzazione: Direttore U.O. di Gastroenterologia
Struttura: Ospedale Morgagni Pierantoni, Forlì – Ospedale Bufalini, Cesena
Ruolo: Direttore U.O. di Gastroenterologia ed Endoscopia Digestiva
Con il contributo non vincolante di
- INNOVAMEDICA
- MALESCI
- CSO PHARMITALIA
- DR FALK
- BOSTON SCIENTIFIC
Domande frequenti
L'evento è accreditato per: Medico Chirurgo (Gastroenterologia, Oncologia, Chirurgia Toracica, Chirurgia Generale, Radiodiagnostica, Anatomia Patologica).
Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Smart ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.